Trial Profile
NovoMix Start - A Multicentre, Open Label, Non-randomised, Non-interventional, Observational Safety Study in Subjects With Type 2 Diabetes Mellitus Starting NovoMix Treatment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Jan 2017
Price :
$35
*
At a glance
- Drugs Insulin aspart/insulin protamine aspart (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Acronyms Start
- 09 Dec 2011 New trial record